Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening

被引：1
|
作者：
Carlsson, Sigrid, V [1 ,2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[3] Univ Gothenburg, Inst Clin Sci, Dept Urol, Sahlgrenska Acad, Gothenburg, Sweden
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2023年 / 41卷 / 02期
基金：
美国国家卫生研究院;
关键词：
Prostate cancer; Prostate specific antigen; Screening; Magnetic resonance imaging; Early detection;
D O I：
10.1016/j.urolonc.2022.04.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [21] PSA testing: an evolving relationship with prostate cancer screening
    J Constantinou
    M R Feneley
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 6 - 13
  • [22] PSA-based parameters and their diagnostic performances in patients with prostate cancer and benign prostatic hyperplasia
    Kocer, Derya
    Karakukcu, Cigdem
    Karaman, Hatice
    Tasdemir, Arzu
    Ergul, Mehmet Ali
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2013, 38 (01): : 37 - 42
  • [23] Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC)
    Villers, A.
    Bessaoud, F.
    Tretarre, B.
    Grosclaude, P.
    Malavaud, B.
    Rebillard, X.
    Iborra, F.
    Daubisse, L.
    Malavaud, S.
    Roobol, M.
    Heijnsdijk, E. A.
    de Koning, H. J.
    Hugosson, J.
    Rischmann, P.
    Soulie, M.
    PROGRES EN UROLOGIE, 2020, 30 (05): : 252 - 260
  • [24] Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer
    Meidenbauer, N
    Harris, DT
    Spitler, LE
    Whiteside, TL
    PROSTATE, 2000, 43 (02) : 88 - 100
  • [25] Patient selection for prostate biopsy: Risk-based or PSA-based?
    Nariculam, J.
    Shabbir, M.
    Thomas, Karen
    Le Roux, P. J.
    Walker, R. M.
    Charig, C. R.
    Parker, C.
    JOURNAL OF CLINICAL UROLOGY, 2012, 5 (03) : 128 - 133
  • [26] Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network
    Stephan, Carsten
    Meyer, Hellmuth-Alexander
    Cammann, Henning
    Nakamura, Terukazu
    Diamandis, Eleftherios P.
    Jung, Klaus
    BIOLOGICAL CHEMISTRY, 2006, 387 (06) : 801 - 805
  • [27] Changing Incidence and Stage Distribution of Prostate Cancer in a Lithuanian Population-Evidence from National PSA-Based Screening Program
    Patasius, Ausvydas
    Smailyte, Giedre
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (23)
  • [28] PSA related screening of prostate cancer. Panic or improvement?
    Fornara, P
    Jurczok, A
    AKTUELLE UROLOGIE, 2004, 35 (01) : 43 - 48
  • [29] Algorithms based on prostate-specific antigen (PSA), free psa, digital rectal examination and prostate volume reduce false-postitive psa results in prostate cancer screening
    Finne, P
    Finne, R
    Bangma, C
    Hugosson, J
    Hakama, M
    Auvinen, A
    Stenman, UH
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (02) : 310 - 315
  • [30] New recommendations for prostate cancer screening with PSA
    Julia-Romero, C.
    Rechi-Sierra, K.
    Juan-Escudero, J. U.
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (05): : 342 - 347
12345